HALEY SCILLION: Open Payments
NPI 1639898513 · MARTIN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$410 in 25 payments from 7 companies in 2025. Trend: 2023 $479 · 2024 $533 · 2025 $410
Food & beverage: $410
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $150 |
| Novo Nordisk Inc | 3 | $95 |
| AstraZeneca Pharmaceuticals LP | 2 | $58 |
| Otsuka America Pharmaceutical, Inc. | 2 | $41 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $26 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| PFIZER INC. | 1 | $17 |
Products named: Ozempic, VRAYLAR, FARXIGA, UBRELVY, REXULTI, CAPLYTA, TRELEGY ELLIPTA, NURTEC ODT.
Industry payments across TN — which companies pay providers there.
